197
Views
19
CrossRef citations to date
0
Altmetric
Drug Profile

β-blockers in the management of hypertension: focus on nebivolol

&
Pages 471-479 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Nida Hanif, Ammara Zamir, Imran Imran, Hamid Saeed, Abdul Majeed, Anees ur Rehman, Waseem Ashraf, Faleh Alqahtani & Muhammad Fawad Rasool. (2023) Clinical pharmacokinetics of nebivolol: a systematic review. Drug Metabolism Reviews 55:4, pages 428-440.
Read now
Bandar Saeed Al-Ghamdi, Dileep Kumar Rohra, Gheid Ali Ibrahim Abuharb, Hala Abdulrahman Alkofide, Nadiah Salem AlRuwaili, Mohamed M. Shoukri & Peter M. B. Cahusac. (2018) Use of beta blockers is associated with hearing loss. International Journal of Audiology 57:3, pages 213-220.
Read now
Samuel J. Stellpflug, Carson R. Harris, Kristin M. Engebretsen, Jon B. Cole & Joel S. Holger. (2010) Intentional overdose with cardiac arrest treated with intravenous fat emulsion and high-dose insulin. Clinical Toxicology 48:3, pages 227-229.
Read now
Michel P. Hermans, Olivier De Coster, Laurence Seidel, Adelin Albert & Philippe Van De Borne. (2009) Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. The QoLaN study. Blood Pressure 18:sup1, pages 5-14.
Read now

Articles from other publishers (15)

Lina S. Farhoumand, Hongtao Liu, Theodora Tsimpaki, Ulrike B. Hendgen-Cotta, Tienush Rassaf, Nikolaos E. Bechrakis, Miltiadis Fiorentzis & Utta Berchner-Pfannschmidt. (2023) Blockade of ß-Adrenergic Receptors by Nebivolol Enables Tumor Control Potential for Uveal Melanoma in 3D Tumor Spheroids and 2D Cultures. International Journal of Molecular Sciences 24:6, pages 5894.
Crossref
Lucian Muresan, Radu Rosu, Gabriel Cismaru, Gabriel Gusetu, Crina Muresan, Raphaël Pedro Martins, Stefan Popa, Jacques Levy & Sebastian Tranca. (2022) Nebivolol for the Treatment of Arrhythmias: a Narrative Review. Current Treatment Options in Cardiovascular Medicine 24:12, pages 231-243.
Crossref
V. Prakash Reddy. 2020. Organofluorine Chemistry. Organofluorine Chemistry 133 214 .
Nasima Olawi, Marcus Krüger, Daniela Grimm, Manfred Infanger & Markus Wehland. (2019) Nebivolol in the treatment of arterial hypertension. Basic & Clinical Pharmacology & Toxicology 125:3, pages 189-201.
Crossref
Fateme Shamekhi Amiri. (2016) Recent advances in the treatment of renal diseases with nebivolol: A literature review. Néphrologie & Thérapeutique 12:3, pages 140-148.
Crossref
Cheol-Ho Kim, Nelson Abelardo, Peera Buranakitjaroen, Rungroj Krittayaphong, Chin Hock Lim, Sung-Ha Park, Nguyen Vinh Pham, Gregorio Rogelio, Bernard Wong & Lip Ping Low. (2016) Hypertension treatment in the Asia-Pacific: the role of and treatment strategies with nebivolol. Heart Asia 8:1, pages 22-26.
Crossref
P. Ravi, R. Vats, S. Joseph & N. Gadekar. (2015) Development and validation of simple, rapid and sensitive LC-PDA ultraviolet method for quantification of Nebivolol in rat plasma and its application to pharmacokinetic studies. Acta Chromatographica 27:2, pages 281-294.
Crossref
James J DiNicolantonio, Hassan Fares, Asfandyar K Niazi, Saurav Chatterjee, Fabrizio D'Ascenzo, Enrico Cerrato, Giuseppe Biondi-Zoccai, Carl J Lavie, David S Bell & James H O'Keefe. (2015) β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature. Open Heart 2:1, pages e000230.
Crossref
C. Briciu, M. Neag, D. Muntean, L. Vlase, C. Bocsan, A. Buzoianu, A.-M. Gheldiu, M. Achim & A. Popa. (2014) A pharmacokinetic drug interaction study between nebivolol and paroxetine in healthy volunteers. Journal of Clinical Pharmacy and Therapeutics 39:5, pages 535-540.
Crossref
Timothy J. Werner, Nabil E. Boutagy, Kristin L. Osterberg, Jose M. Rivero & Kevin P. Davy. (2013) Singular and combined effects of nebivolol and lifestyle modification on large artery stiffness in hypertensive adults. Therapeutic Advances in Cardiovascular Disease 7:6, pages 285-292.
Crossref
Ming-Guo Feng, Minolfa C. Prieto & L. Gabriel Navar. (2012) Nebivolol-induced vasodilation of renal afferent arterioles involves β 3 -adrenergic receptor and nitric oxide synthase activation . American Journal of Physiology-Renal Physiology 303:5, pages F775-F782.
Crossref
M.J. Rodríguez Arcas, E. García-Jiménez, F. Martínez-Martínez & P. Conesa-Zamora. (2011) Papel del citocromo P450 en la farmacocinética y en la farmacogenética de los fármacos antihipertensivos. Farmacia Hospitalaria 35:2, pages 84-92.
Crossref
Fadi El-Rami, Hampartsoum Barsoumian, Joseph Simaan & Alexander M. Abdelnoor. (2010) The effect of nebivolol on the production of nitric oxide induced by bacterial lipopolysaccharide and peptidoglycan in mice. Natural Science 02:12, pages 1360-1368.
Crossref
Gordon M. Cragg, David J. Newman & David G.I. Kingston. 2010. Comprehensive Natural Products II. Comprehensive Natural Products II 5 39 .
Vasilios Papademetriou. (2009) Comparison of Nebivolol Monotherapy Versus Nebivolol in Combination With Other Antihypertensive Therapies for the Treatment of Hypertension. The American Journal of Cardiology 103:2, pages 273-278.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.